These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9066635)

  • 21. Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET.
    Lin JC; Scherer SW; Tougas L; Traverso G; Tsui LC; Andrulis IL; Jothy S; Park M
    Oncogene; 1996 Nov; 13(9):2001-8. PubMed ID: 8934547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables.
    Johannsdottir HK; Johannesdottir G; Agnarsson BA; Eerola H; Arason A; Johannsson OT; Heikkilä P; Egilsson V; Olsson H; Borg A; Nevanlinna H; Barkardottir RB
    Anticancer Res; 2004; 24(5A):2681-7. PubMed ID: 15521105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes.
    Takita K; Sato T; Miyagi M; Watatani M; Akiyama F; Sakamoto G; Kasumi F; Abe R; Nakamura Y
    Cancer Res; 1992 Jul; 52(14):3914-7. PubMed ID: 1617666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
    Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
    Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping of a new target region of allelic loss to a 6-cM interval at 21q21 in primary breast cancers.
    Ohgaki K; Iida A; Kasumi F; Sakamoto G; Akimoto M; Nakamura Y; Emi M
    Genes Chromosomes Cancer; 1998 Nov; 23(3):244-7. PubMed ID: 9790505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
    Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
    Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer.
    Theile M; Seitz S; Arnold W; Jandrig B; Frege R; Schlag PM; Haensch W; Guski H; Winzer KJ; Barrett JC; Scherneck S
    Oncogene; 1996 Aug; 13(4):677-85. PubMed ID: 8761288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9.
    Cairns P; Shaw ME; Knowles MA
    Oncogene; 1993 Apr; 8(4):1083-5. PubMed ID: 8096074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of heterozygosity at chromosome 1p in human breast cancer.
    Ragnarsson G; Sigurdsson A; Eiriksdottir G; Barkardottir R; Jonasson J; Ingvarsson S
    Int J Oncol; 1996 Oct; 9(4):731-6. PubMed ID: 21541576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of heterozygosity analysis of a candidate gastric carcinoma tumor suppressor locus at 7q31.
    Xia JC; Weng DS; Li JT; Qin HD; Mai SJ; Feng BJ; Fan Q; Feng QS; Huang LX; Yu XJ; Pan ZZ; Li YQ; Wang QJ; Zhan YQ; Chen SP; He J; Huang WL; Wu PH; Zeng YX
    Cancer Genet Cytogenet; 2006 Apr; 166(2):166-72. PubMed ID: 16631475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of two separate regions on chromosome 3p in breast cancers.
    Chen LC; Matsumura K; Deng G; Kurisu W; Ljung BM; Lerman MI; Waldman FM; Smith HS
    Cancer Res; 1994 Jun; 54(11):3021-4. PubMed ID: 7910519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas.
    Schwerdtle RF; Winterpacht A; Störkel S; Brenner W; Hohenfellner R; Zabel B; Huber C; Decker HJ
    Cancer Res; 1997 Nov; 57(22):5009-12. PubMed ID: 9371493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of the FHIT gene in breast cancer: association with tumor progression and patient survival.
    Ingvarsson S; Sigbjornsdottir BI; Huiping C; Jonasson JG; Agnarsson BA
    Cancer Detect Prev; 2001; 25(3):292-8. PubMed ID: 11425271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prognostic significance of loss of heterozygosity in breast cancer].
    Iwase H; Iwata H; Toyama T; Hara Y; Omoto Y; Kobayashi S
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():426-30. PubMed ID: 9589047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The frequency and mechanism of loss of heterozygosity on chromosome 11q in breast cancer.
    Tomlinson IP; Nicolai H; Solomon E; Bodmer WF
    J Pathol; 1996 Sep; 180(1):38-43. PubMed ID: 8943813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of association between LOH in the 9p region and clinicopathologic parameters in primary breast cancer.
    Vieira de Oliveira SF; Oliveira MM; Urban CA; de Lima RS; Cavalli IJ; Ribeiro EM
    Cancer Genet Cytogenet; 2010 Jul; 200(1):23-7. PubMed ID: 20513530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted.
    Cropp CS; Champeme MH; Lidereau R; Callahan R
    Cancer Res; 1993 Dec; 53(23):5617-9. PubMed ID: 8242614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A new marker of aggressivity of breast cancers: loss of heterozygote on chromosome 7q].
    Bièche I; Champème MH; Matifas F; Hacène K; Lidereau R
    Bull Cancer; 1992; 79(9):865-72. PubMed ID: 1486222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.